Details for New Drug Application (NDA): 202873
✉ Email this page to a colleague
The generic ingredient in CLOZAPINE is clozapine. There are thirteen drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the clozapine profile page.
Summary for 202873
Tradename: | CLOZAPINE |
Applicant: | Accord Hlthcare |
Ingredient: | clozapine |
Patents: | 0 |
Suppliers and Packaging for NDA: 202873
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLOZAPINE | clozapine | TABLET;ORAL | 202873 | ANDA | Accord Healthcare Inc. | 16729-141 | 16729-141-01 | 100 TABLET in 1 BOTTLE (16729-141-01) |
CLOZAPINE | clozapine | TABLET;ORAL | 202873 | ANDA | Accord Healthcare Inc. | 16729-141 | 16729-141-16 | 500 TABLET in 1 BOTTLE (16729-141-16) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Nov 25, 2015 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
Approval Date: | Nov 25, 2015 | TE: | AB | RLD: | No |
Complete Access Available with Subscription